Addison Capital CO Merck & Co., Inc. Transaction History

Addison Capital CO

$238 Million
Q3 2024

A detailed history of Addison Capital CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Addison Capital CO holds 31,411 shares of MRK stock, worth $3.12 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

31,411

Previous 31,406 0.02%

Holding current value

$3.12 Million

Previous $3.89 Million 8.26%

% of portfolio

1.5%

Previous 1.73%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$111.15 - $128.97 $555 - $644	5 Added 0.02%	31,411 $3.57 Million
Q2 2024 Jul 25, 2024	BUY	$123.8 - $132.96 $119,467 - $128,306	965 Added 3.17%	31,406 $3.89 Million
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $8,379 - $9,764	74 Added 0.24%	30,441 $4.02 Million
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $2.46 Million - $2.68 Million	24,571 Added 423.93%	30,367 $3.31 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $30,473 - $33,841	296 Added 5.38%	5,796 $596,000
Q2 2023 Aug 18, 2023	BUY	$108.61 - $118.38 $19,984 - $21,781	184 Added 3.46%	5,500 $634,000
Q1 2023 Apr 13, 2023	SELL	$102.94 - $114.86 $357,613 - $399,023	-3,474 Reduced 39.52%	5,316 $566,000
Q4 2022 Jan 09, 2023	BUY	$87.44 - $112.11 $9,793 - $12,556	112 Added 1.29%	8,790 $975,000
Q3 2022 Oct 12, 2022	BUY	$84.53 - $94.96 $20,287 - $22,790	240 Added 2.84%	8,678 $747,000
Q2 2022 Jul 11, 2022	SELL	$83.49 - $94.64 $27,050 - $30,663	-324 Reduced 3.7%	8,438 $769,000
Q1 2022 Apr 11, 2022	SELL	$73.51 - $82.4 $10,291 - $11,536	-140 Reduced 1.57%	8,762 $719,000
Q4 2021 Jan 18, 2022	BUY	$72.28 - $90.54 $205,130 - $256,952	2,838 Added 46.8%	8,902 $682,000
Q3 2021 Oct 12, 2021	SELL	$71.68 - $78.83 $10,752 - $11,824	-150 Reduced 2.41%	6,064 $455,000
Q2 2021 Jul 16, 2021	BUY	$70.31 - $77.77 $76,145 - $84,224	1,083 Added 21.11%	6,214 $483,000
Q1 2021 Apr 12, 2021	BUY	$68.86 - $81.11 $39,801 - $46,881	578 Added 12.69%	5,131 $396,000
Q4 2020 Jan 12, 2021	SELL	$71.77 - $79.65 $2,655 - $2,947	-37 Reduced 0.81%	4,553 $372,000
Q3 2020 Oct 13, 2020	SELL	$73.18 - $82.95 $8,635 - $9,788	-118 Reduced 2.51%	4,590 $381,000
Q2 2020 Jul 16, 2020	BUY	$70.42 - $80.13 $12,816 - $14,583	182 Added 4.02%	4,708 $364,000
Q1 2020 Apr 13, 2020	BUY	$63.36 - $87.82 $2,344 - $3,249	37 Added 0.82%	4,526 $348,000
Q4 2019 Jan 10, 2020	BUY	$77.58 - $87.54 $22,730 - $25,649	293 Added 6.98%	4,489 $408,000
Q3 2019 Oct 10, 2019	SELL	$76.08 - $82.93 $5,629 - $6,136	-74 Reduced 1.73%	4,196 $353,000
Q2 2019 Jul 11, 2019	BUY	$69.84 - $81.59 $31,078 - $36,307	445 Added 11.63%	4,270 $358,000
Q3 2018 Oct 09, 2018	BUY	$57.69 - $67.84 $23,076 - $27,136	400 Added 11.68%	3,825 $271,000
Q2 2018 Jul 11, 2018	BUY	$50.83 - $59.72 $174,092 - $204,541	3,425 New	3,425 $208,000
Q4 2017 Jan 19, 2018	SELL	$51.62 - $61.64 $166,474 - $198,789	-3,225 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$58.67 - $63.13 $189,210 - $203,594	3,225	3,225 $206,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Capital CO, based on Form 13F filings with the SEC.

News

Stay updated on Addison Capital CO with notifications on news.

Account

Addison Capital CO Merck & Co., Inc. Transaction History